XML 89 R57.htm IDEA: XBRL DOCUMENT v3.21.2
Sale of Future Revenue (Details) - USD ($)
$ in Thousands
1 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended 8 Months Ended 63 Months Ended
Nov. 03, 2020
Nov. 30, 2020
Dec. 31, 2020
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2021
Disaggregation of Revenue [Line Items]                  
Payments for loan acquisition costs           $ 2,909      
Revenues       $ 15,345 $ 21,675 26,467 $ 30,440    
Royalty                  
Disaggregation of Revenue [Line Items]                  
Revenues           (1,034)      
Marathon Pangolin Royalty LLC | Maximum                  
Disaggregation of Revenue [Line Items]                  
Proceeds from sale of future revenue $ 125,000                
License Agreement with Sunovion Pharmaceuticals, Inc.                  
Disaggregation of Revenue [Line Items]                  
Revenues                 $ 22,000
Minimum annual royalty receivable       $ 1,000 $ 1,000 $ 1,000 $ 1,000 $ 1,000 $ 1,000
Guaranteed royalty period         8 years 8 years      
License Agreement with Sunovion Pharmaceuticals, Inc. | Royalty                  
Disaggregation of Revenue [Line Items]                  
Revenues         $ 8,000        
Monetization Agreement                  
Disaggregation of Revenue [Line Items]                  
Effective annual interest rate 24.90%                
Monetization Agreement | Marathon Pangolin Royalty LLC                  
Disaggregation of Revenue [Line Items]                  
Proceeds from sale of future revenue $ 40,000   $ 10,000         $ 50,000  
Proceeds from debt, contingent on additional milestones   $ 75,000